This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Langevelde, P.
Right arrow Articles by Groeneveld, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Langevelde, P.
Right arrow Articles by Groeneveld, P. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 08 1997, 1682-1685, Vol 41, No. 8
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth

P van Langevelde, JT van Dissel, CJ Meurs, J Renz and PH Groeneveld
Department of Infectious Diseases, Leiden University Hospital, The Netherlands.

Production of exotoxins by staphylococci and streptococci may lead to the development of toxic shock syndrome (TSS). Because clindamycin inhibits exotoxin production, its use has been advocated for the treatment of TSS. However, the bacteriostatic action of clindamycin might be a disadvantage for the treatment of overwhelming infections. We investigated the effects of flucloxacillin and gentamicin on exotoxin production, because incubation with these antibiotics combines bactericidal action with protein synthesis inhibition. Staphylococcus aureus during the logarithmic and stationary phases of growth was incubated with either clindamycin, flucloxacillin, or a combination of flucloxacillin and gentamicin at concentrations of 2 or 10 times the MIC. In logarithmic-phase cultures clindamycin had a static effect on bacterial growth. After incubation with flucloxacillin, either alone or in combination with gentamicin, a rapid and large reduction in the number of viable bacteria was demonstrated. In stationary-phase cultures none of the antibiotics significantly changed the number of viable bacteria. TSS toxin 1 (TSST-1) production during logarithmic- phase growth was inhibited by > or =95% by all antibiotics. In stationary-phase cultures, clindamycin, flucloxacillin, and the combination of flucloxacillin and gentamicin inhibited TSST-1 production by 95, 30, and 75%, respectively, compared with the level of exotoxin production in the controls. The present results indicate that clindamycin inhibits TSST-1 production and exerts bacteriostatic activity in both bacterial growth phases. Because the combination of flucloxacillin and gentamicin combines the inhibition of exotoxin production with high bactericidal activity at least in logarithmic- phase cultures, it should be considered an alternative to clindamycin for the treatment of exotoxin-mediated diseases, especially in patients with overwhelming infections.


This article has been cited by other articles:

  • Nathwani, D., Morgan, M., Masterton, R. G., Dryden, M., Cookson, B. D., French, G., Lewis, D., on behalf of the British Society for Antimicrobial, (2008). Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61: 976-994 [Abstract] [Full Text]  
  • Dumitrescu, O., Boisset, S., Badiou, C., Bes, M., Benito, Y., Reverdy, M.-E., Vandenesch, F., Etienne, J., Lina, G. (2007). Effect of Antibiotics on Staphylococcus aureus Producing Panton-Valentine Leukocidin. Antimicrob. Agents Chemother. 51: 1515-1519 [Abstract] [Full Text]  
  • Romero-Tabarez, M., Jansen, R., Sylla, M., Lunsdorf, H., Haussler, S., Santosa, D. A., Timmis, K. N., Molinari, G. (2006). 7-O-Malonyl Macrolactin A, a New Macrolactin Antibiotic from Bacillus subtilis Active against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and a Small-Colony Variant of Burkholderia cepacia.. Antimicrob. Agents Chemother. 50: 1701-1709 [Abstract] [Full Text]  
  • Micek, S. T., Dunne, M., Kollef, M. H. (2005). Pleuropulmonary Complications of Panton-Valentine Leukocidin-Positive Community-Acquired Methicillin-Resistant Staphylococcus aureus: Importance of Treatment With Antimicrobials Inhibiting Exotoxin Production. Chest 128: 2732-2738 [Abstract] [Full Text]  
  • Ohlsen, K., Ziebuhr, W., Koller, K.-P., Hell, W., Wichelhaus, T. A., Hacker, J. (1998). Effects of Subinhibitory Concentrations of Antibiotics on Alpha-Toxin (hla) Gene Expression of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus Isolates. Antimicrob. Agents Chemother. 42: 2817-2823 [Abstract] [Full Text]